文献速递姑息放疗与转移瘤放疗物理与技术

加速放疗路径:放疗科同日计划与治疗的系统综述

Accelerated radiotherapy pathways: a systematic review on same-day planning and treatment in radiation oncology.
PubMed 文献 · Clin Transl Radiat Oncol · 2026-03-22

该系统综述检索PubMed、Embase和Cochrane Library,纳入13项研究,评估同日完成咨询、模拟、计划与治疗的可行性。证据主要支持姑息场景,患者满意度良好;仅3项研究报告治疗准确性, curative场景及卫生系统影响仍需更大前瞻性研究。

要点

  • 同日放疗证据以姑息治疗为主(54%),骨转移是最常见适应证。
  • 立体定向放疗(54%)和低分次外照射(38%)是最常用技术。
  • 仅3项研究(23%)评估治疗准确性,治愈性场景证据不足。

核心结论

  • 当前证据支持同日放疗的可行性,尤其在姑息治疗场景,患者满意度良好,有报告时治疗准确性可靠。
  • 需要更大规模前瞻性研究来标准化工作流程并评估治愈性场景的结局及卫生系统、财务和法律影响。

研究设计与样本

  • 系统综述,遵循PRISMA 2020指南,于2025年8月在PubMed、Embase和Cochrane Library检索。
  • 纳入实体恶性肿瘤放疗且在同一天完成计划与治疗的前瞻性或观察性研究报告。
  • 共识别124条记录,13项研究符合纳入标准,其中9项为前瞻性、4项为回顾性。
  • 中位研究样本量为39例患者,中位ECOG体能状态评分为1。

主要发现

  • 治疗意图以姑息为主(54%),其次为治愈性(31%)和消融性(15%)。
  • 骨转移是最常见适应证;治愈性治疗包括肺、前列腺、脑、乳腺和葡萄膜肿瘤。
  • 立体定向放疗(54%)和低分次外照射放疗(38%)是最常用的技术。
  • 操作时间范围为25至470分钟。
  • 三项研究报告患者满意度,结果一致良好;仅三项研究(23%)评估治疗准确性。

关键数值与推荐

  • 纳入标准为实体恶性肿瘤放疗且在同一天完成治疗计划与治疗的前瞻性或观察性报告。
  • 中位研究样本量为39例患者,中位ECOG体能状态评分为1。
  • 治疗意图分布:姑息54%、治愈性31%、消融性15%。
  • 技术使用:立体定向放疗54%、低分次外照射放疗38%。
  • 操作时间范围25至470分钟。

临床怎么用

  • 同日放疗可优先考虑用于姑息治疗场景,尤其是骨转移患者。
  • 实施同日路径时可选择立体定向放疗或低分次外照射放疗技术。
  • 开展同日放疗项目时需关注操作时间跨度较大(25至470分钟)对工作流程的影响。

局限性

  • 前瞻性临床证据仍然有限。
  • 仅三项研究(23%)评估治疗准确性。
  • 治愈性场景的结局证据不足。
  • 卫生系统、财务和法律影响未充分评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION AND BACKGROUND: Same-day radiotherapy, integrating consultation, simulation, planning, and treatment within a single day, is an emerging approach in radiation oncology. Advances in imaging integration, automation, and adaptive planning have enabled shorter timelines between consultation and treatment initiation, but prospective clinical evidence remains limited. This systematic review evaluates indications, feasibility, treatment accuracy, and patient satisfaction with same-day radiotherapy. MATERIALS AND METHODS: A systematic literature search was conducted in August 2025 using PubMed, Embase, and the Cochrane Library in accordance with PRISMA 2020 guidelines. Eligible studies included prospective or observational reports of radiotherapy for solid malignancies delivered on the same day as treatment planning. RESULTS: Of 124 identified records, 13 studies met inclusion criteria. Most were prospective (n = 9), with four retrospective studies. Median study size was 39 patients, with a median ECOG performance status of 1. Treatment intent was predominantly palliative (54%), followed by curative (31%) and ablative (15%). Bone metastases were the most common indication; curative treatments included lung, prostate, brain, breast, and uveal tumors. Stereotactic radiotherapy (54%) and hypofractionated external-beam radiotherapy (38%) were most frequently used. Procedure times ranged from 25 to 470 min. Patient satisfaction, reported in three studies, was consistently good. Treatment accuracy was only assessed in three (23%) studies. CONCLUSION: Current evidence supports the feasibility of same-day radiotherapy, particularly in palliative settings, with favorable patient satisfaction and robust treatment accuracy, where reported. Larger prospective studies are required to standardize workflows and assess outcomes in curative settings, as well as health-system, financial, and legal implications.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Heusel A, Gabrys H, Wilke L, et al. Accelerated radiotherapy pathways: a systematic review on same-day planning and treatment in radiation oncology. Clin Transl Radiat Oncol. 2026. PMID: 41938986. doi:10.1016/j.ctro.2026.101145

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。